Oscar Health Inc expected to post a loss of 49 cents a share - Earnings Preview

Oscar Health

03/11/2023 16:23

* Oscar Health Inc  OSCR.N   OSCR.K  is expected to show a
rise in
quarterly revenue when it reports  results on November 7. 
    * The New York City-based  company is expected to report  a
45.5% increase in revenue to $1.423 billion from $978.43 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Oscar Health Inc is
for a
loss of 49 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Oscar
Health Inc
is $9​, above​ its last closing price of $5.51. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.22       -0.23      -0.07     Beat    69.6
 Mar. 31 2023  -0.04       -0.05      -0.18     Missed  -254.7
 Dec. 31 2022  -1.09       -1.16      -1.05     Beat    9.5​
 Sep. 30 2022  -0.72       -0.73      -0.91     Missed  -24.6
 ​​Jun.        -0.51       -0.48      -0.53     Missed  -10.8
 30 2022                                                
 Mar. 31 2022  -0.21       -0.21      -0.36     Missed  -68.6​
 Dec. 31 2021  -0.85       -0.96      -0.95     Beat    1.5
 Sep. 30 2021  -0.66       -0.66      -1.02     Missed  -54.7
 This summary was machine generated November 3 at 16:23 GMT.  All
figures in US dollars  unless otherwise stated